IN BRIEF: AstraZeneca chief executive joins Agilent Technologies board

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

AstraZeneca PLC - Cambridge-based pharmaceutical and biotechnology company - Says Chief Executive Officer Pascal Soriot has been appointed a director of Santa Clara, California-based laboratory software and services company Agilent Technologies Inc, effective immediately.

Current AstraZeneca stock price: 10,534.00 pence, up 1.1% in London on Wednesday afternoon

12-month change: down 15%

Current Agilent Tech stock price: $113.48, closed marginally higher on Tuesday in New York

12-month change: down 27%

Copyright 2025 Alliance News Ltd. All Rights Reserved.